Search research articles
Contact Us
Filters
Showing results (531-540 of 692) with videos related to
Page
of 70
Sort By:
The Lancet. Oncology
|
December 17, 2016
Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis
Julia Wilkerson, Kald Abdallah, Charles Hugh-Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2008
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer
Dana Rathkopf, Michael A Carducci, Michael J Morris, et al.
The Journal of Clinical Investigation
|
January 6, 2006
Differential exoprotease activities confer tumor-specific serum peptidome patterns
Josep Villanueva, David R Shaffer, John Philip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
L M Butler, Y Webb, D B Agus, et al.
The Journal of Clinical Investigation
|
January 26, 2013
β4 Integrin signaling induces expansion of prostate tumor progenitors
Toshiaki Yoshioka, Javier Otero, Yu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2017
Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone
Dana E Rathkopf, Emmanuel S Antonarakis, Neal D Shore, et al.
Journal of Oncology Practice
|
August 15, 2013
Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure
Karen A Autio, Antonia V Bennett, Xiaoyu Jia, et al.
British Journal of Cancer
|
October 31, 2013
First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer
D Bianchini, A Omlin, C Pezaro, et al.
Urology
|
December 29, 2020
Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary
Martin R Hofmann, Maha Hussain, Scott M Dehm, et al.
Vaccine
|
April 8, 2004
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
Polly D Gregor, Jedd D Wolchok, Cristina R Ferrone, et al.
Page
of 70
Search research articles
Search
Showing results (531-540 of 692) with videos related to
Sort By:
Page
of 70
The Lancet. Oncology
|
December 17, 2016
Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis
Julia Wilkerson, Kald Abdallah, Charles Hugh-Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2008
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer
Dana Rathkopf, Michael A Carducci, Michael J Morris, et al.
The Journal of Clinical Investigation
|
January 6, 2006
Differential exoprotease activities confer tumor-specific serum peptidome patterns
Josep Villanueva, David R Shaffer, John Philip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
L M Butler, Y Webb, D B Agus, et al.
The Journal of Clinical Investigation
|
January 26, 2013
β4 Integrin signaling induces expansion of prostate tumor progenitors
Toshiaki Yoshioka, Javier Otero, Yu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2017
Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone
Dana E Rathkopf, Emmanuel S Antonarakis, Neal D Shore, et al.
Journal of Oncology Practice
|
August 15, 2013
Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure
Karen A Autio, Antonia V Bennett, Xiaoyu Jia, et al.
British Journal of Cancer
|
October 31, 2013
First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer
D Bianchini, A Omlin, C Pezaro, et al.
Urology
|
December 29, 2020
Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary
Martin R Hofmann, Maha Hussain, Scott M Dehm, et al.
Vaccine
|
April 8, 2004
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
Polly D Gregor, Jedd D Wolchok, Cristina R Ferrone, et al.
Page
of 70